基于多价抗原蛋白的通用型活疫苗平台对抗多种血清型猪链球菌
本研究开发了一种基于多价抗原蛋白SE6的通用型活疫苗候选,利用猪霍乱沙门菌载体在体内递送该抗原。免疫小鼠的抗血清对多种血清型猪链球菌产生更广谱且强效的调理吞噬反应,该载体在体内对猪链球菌血清型2、7和9提供高效保护。
要点
- 猪链球菌是猪群长期威胁,因食源性传播已成为人类脑膜炎重要病因。
- 目前尚无针对该病的疫苗,尤其缺乏可应对多种血清型的通用疫苗。
- SE6递送载体免疫小鼠抗血清对多种血清型产生更广谱强效调理吞噬反应。
核心结论
- 基于多价抗原蛋白SE6的猪霍乱沙门菌载体活疫苗候选在体内对猪链球菌血清型2、7和9提供高效保护。
研究设计与样本
- 本研究开发基于多价抗原蛋白SE6的通用型活疫苗候选,采用猪霍乱沙门菌载体在体内生产和递送多价抗原。
主要发现
- SE6蛋白在猪霍乱沙门菌载体中高效表达并递送至宿主淋巴系统。
- 免疫小鼠的SE6递送载体抗血清对多种血清型猪链球菌产生更广谱且强效的调理吞噬反应。
- SE6递送载体在体内对猪链球菌血清型2、7和9提供高效保护。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Streptococcus suis (S. suis) is a major pathogen that poses a long-term threat to swine populations. Due to its foodborne transmission, this pathogen has recently emerged as a leading cause of meningitis in humans, presenting a significant public health challenge. Currently, no vaccine is available to combat this disease, particularly a universal vaccine capable of addressing multiple subtypes of S. suis. In this study, we developed a universal live vaccine candidate against multiple serotypes S. suis based on the polyvalent antigen protein SE6. A live Salmonella Choleraesuis (S. Choleraesuis) vector was employed for the production and in vivo delivery of the polyvalent antigen. The SE6 protein was efficiently expressed within the S. Choleraesuis vector and delivered to the host's lymphatic system. The antiserum of mice immunized with SE6-delivering S. Choleraesuis vector produced a broader and potent opsonophagocytic response against multiple serotypes of S. suis. Finally, the SE6-delivering S. Choleraesuis vector demonstrated high efficacy in providing protection against S. suis serotypes 2, 7, and 9 in vivo.
引用
- Li W, Li YA, Wang S, et al. A universal live vaccine platform against multiple serotypes Streptococcus suis based on polyvalent antigen protein. Vaccine. 2025. PMID: 39778475. doi:10.1016/j.vaccine.2024.126700
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。